Israel-Cannabis and Citrine join to form iBOT

Israel-Cannabis and Citrine Biotech and Cannabis Investment Funds announced the establishment of iBOT: Israel Botanicals, a botanical nutraceutical company located in central Israel, on Thursday.

iBOT has received full certification by the Israeli Ministry of Health and ISO certification bodies accrediting iBOT to GMP, ISO 9001 and HACCP standards. 

iBOT has stated they will continue offering vitamin and herbal formulations in tablets, capsules, syrups, and tinctures, offered by the previous makeup, but anticipates offering a line of new full-spectrum botanical supplements in 2020.

   

“iBOT’s mission is to bring the best of Israeli R&D, innovation and life science experience to the world of botanicals and the evolving Cannabis industry. As Israel has led the world in BioTech and CannaTech innovation, we look to bring the same level of innovation to the world of botanical health. Starting with GMP as a quality platform, we plan to bring a new level of scientific investigation to better understand and control the products we manufacture. We will then combine it with physician and market education to form the platform for our growth in an already growing market,” said iBOT CEO Ronnie Eshel.

iBOT now begins the process of licensing the facility with Yakar (The Medical Cannabis Unit of the Ministry of Health) for the production and distribution of IMC-GMP cannabis products.

Ora Soffer, CEO of Citrine Biotech and Cannabis Investment Funds, said, “We are excited to partner with iCAN and look forward to working with the team at iBOT to promote the research and development of Botanical products, including those from the Cannabis plant. We have joined forces with first-line professionals and believe in the huge potential of Cannabis and other botanical products to bring natural relief and cures to many.”